This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Life Technologies Introduces Ion AmpliSeq™ Community Panels

CARLSBAD, Calif., Nov. 7, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced Ion AmpliSeq™ Community Panels, a community-driven solution to gene panel sequencing that leverages the expertise of scientific thought leaders and the Ion Community to create gene panels for conditions ranging from cancer to inherited diseases. Life Technologies also announced an upgrade to its Ion Reporter™ Software, which further simplifies sequencing data analysis and interpretation with an automated point-and-click workflow that makes informatics accessible to everyone.

Ion AmpliSeq™ Community Panels are built on the same breakthrough technology that powers the Ion AmpliSeq™ Ready-to-Use Panels and the Ion AmpliSeq™ Custom Panels. Since introduction just a year ago, Ion AmpliSeq™ Ready-to-Use Panels for over 40,000 reactions have been sold for cancer and inherited disease research. Additionally, in just seven months more than 900 scientists have designed their own Ion AmpliSeq™ Custom Panels online with Ion AmpliSeq™ Designer on ampliseq.com, a simple web-based assay design tool.

Ion AmpliSeq™ Community Panels are developed in collaboration with leading scientists who draw on their expertise in a specific disease area to select gene content for panels. These panels are then verified and made available to the entire Ion Community.  Users have the option of adding or removing gene content to precisely fit their research needs, providing the ultimate flexibility.

One of the first panels was developed by eight leading European researchers who worked together with Life Technologies scientists to develop a 22-gene Ion AmpliSeq™ Community Panel for lung and colon cancer. Click here to see a video interview with the OncoNetwork members. The panel analyzes more than 500 mutations in a single-tube assay that requires just 10 ng of DNA input per primer pool, about 25-fold less than alternative gene panel approaches.   The Ion AmpliSeq™ workflow is a simple PCR reaction that takes just 3.5 hours turn-around time.

"Using classical methods to screen for mutations one at a time requires so much DNA sample, you often can't look at all the mutations you want," said Dr. Pierre Laurent-Puig, M.D., Ph.D., Professor at the Paris - Descartes University Medical School and a member of the OncoNetwork Consortium. "We have developed a tool that allows us to characterize tumors very easily, using only 10 ng of sample to screen more than 500 COSMIC mutations. Having these kits in our hands will accelerate throughput of the characterization of tumors and make personalized medicine a reality."

The research institutions that developed the panel – dubbed the OncoNetwork – include Centro Ricerche Oncologiche Mercogliano, Italy; Leiter Genetik / Molekularbiologie Viollier AG, Switzerland; University of Warwick, UK; Institut Gustave Roussy France; Radboud University Nijmegen Medical Centre, The Netherlands; Universite Paris Descartes Centre, Universitaire des Saints-Peres, France; St James' Hospital, Dublin EIRE.

In addition to the OncoNetwork panel, Life Technologies is working with other leading researchers to develop new Ion AmpliSeq Community Panels: Ion AmpliSeq™ AML Panel, for acute myeloid Leukemia research; Ion AmpliSeq™ BRCA1/2 Panel, for breast and ovarian cancer research; Ion AmpliSeq™ Cardio Panel, for heart disease research; Ion AmpliSeq™ CFTR Panel, for cystic fibrosis research and the Ion AmpliSeq™ TP53 Panel, for cancer research.  Ion AmpliSeq™ Community Panels are verified by the same researchers who designed the gene content.  All of these designs are available today for review at ampliseq.com. Join the 13,500-member Ion Community today to find out more about the program or to contribute to creating Ion AmpliSeq Community Panels.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,994.83 +282.17 1.59%
S&P 500 2,087.95 +26.93 1.31%
NASDAQ 4,945.8810 +54.6620 1.12%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs